15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 8.5% per year over the past 5 years.
Net income has grown faster than revenue (9.5% vs 8.5% per year).
Operating margin has been roughly flat, at 11.5% in the latest year.
Free cash flow has declined 12.2% per year over the past 5 years.
Financial health
Total debt ($4.8B) exceeds cash ($138M); net debt is $4.7B.
Total debt has grown slower than revenue (4.5% vs 8.5% per year).
Operating income covered interest expense 13× in the latest year, down from 13× 5 years ago.
Total debt is 1.8× EBITDA.
Shareholder returns
Dividends have been paid for 9 consecutive years, consuming 3.4% of earnings and 6.0% of free cash flow.
The dividend has grown 24.2% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$17.4B
$1.5B
0.0%
11.5%
$849M
$4.8B
$138M
2024
$15.8B
$1.1B
0.0%
10.6%
$1.1B
$4.5B
$126M
2023
$14.3B
$718M
0.0%
8.2%
$525M
$4.9B
$119M
2022
$13.4B
$676M
0.0%
7.5%
$262M
$4.8B
$103M
2021
$12.6B
$992M
0.0%
10.8%
$28M
$4.2B
$115M
2020
$11.6B
$944M
0.0%
11.8%
$1.6B
$3.9B
$1.2B
2019
$11.4B
$815M
0.0%
10.7%
$804M
$4.0B
$61M
2018
$10.8B
$780M
0.0%
10.9%
$610M
$4.0B
$105M
2017
$10.4B
$752M
0.0%
12.3%
$690M
$4.0B
$74M
2016
$9.8B
$702M
0.0%
13.1%
$814M
$4.1B
$34M
2015
—
$681M
—
—
$689M
$3.4B
$61M
2014
—
$545M
—
—
$645M
$3.3B
$32M
2013
—
$511M
—
—
$526M
$3.3B
$17M
2012
—
$443M
—
—
$436M
$3.7B
$23M
2011
—
$398M
—
—
$425M
$3.7B
$41M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$4.5B
$349M
0.0%
11.2%
$184M
$4.7B
$119M
Dec '25
$4.5B
$446M
0.0%
11.5%
$293M
$4.8B
$138M
Sep '25
$4.5B
$373M
0.0%
11.6%
$152M
$4.7B
$113M
Jun '25
$4.3B
$353M
0.0%
11.7%
$283M
$4.6B
$138M
Mar '25
$4.1B
$317M
0.0%
11.1%
$121M
$4.6B
$127M
Dec '24
$4.1B
$332M
0.0%
11.5%
$412M
$4.5B
$126M
Sep '24
$4.0B
$259M
0.0%
9.7%
$85M
$4.7B
$106M
Jun '24
$3.9B
$289M
0.0%
11.2%
$438M
$4.5B
$129M
Mar '24
$3.8B
$262M
0.0%
10.1%
$188M
$4.9B
$112M
Dec '23
$3.7B
$216M
0.0%
8.9%
$246M
$4.9B
$119M
Sep '23
$3.6B
$167M
0.0%
8.0%
-$38M
$4.9B
$81M
Jun '23
$3.5B
$171M
0.0%
7.9%
$195M
$4.7B
$79M
Mar '23
$3.5B
$163M
0.0%
8.0%
$122M
$4.8B
$110M
Dec '22
$3.4B
$175M
0.0%
7.6%
$133M
$4.8B
$103M
Sep '22
$3.3B
$183M
0.0%
8.3%
$59M
$4.7B
$75M
Jun '22
$3.3B
$164M
0.0%
7.0%
-$175M
$4.7B
$133M
Mar '22
$3.3B
$154M
0.0%
7.1%
$245M
$4.3B
$106M
Dec '21
$3.3B
$239M
0.0%
9.6%
$132M
$4.2B
$115M
Sep '21
$3.2B
$218M
0.0%
10.0%
$258M
$3.8B
$190M
Jun '21
$3.2B
$325M
0.0%
13.7%
-$187M
$3.6B
$199M
Valuation over time
How the market has priced UHS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 11.5× (Mar '23) to 5.9× (Jun '26).
The price-to-sales ratio has fallen from 0.6× (Mar '23) to 0.5× (Jun '26).
The dividend yield has fallen from 0.8% (Mar '23) to 0.6% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is UHS growing its revenue and profit?
Over the past 5 years, Universal Health Services's revenue has grown 8.5% per year, and net income grown 9.5% per year. These are computed facts, not advice.
How much debt does UHS have?
As of FY2025, Universal Health Services reported $4.8B of total debt against $138M of cash; operating income covered interest expense 13×.
What is UHS's profit margin?
In FY2025, gross margin was —, operating margin 11.5%, and net margin 8.6%.
What is UHS's P/E ratio?
As of Jun '26, Universal Health Services traded at a price-to-earnings ratio of about 5.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.